Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Devote $2.5M to Genomic, Proteomic Premature Birth Research

NEW YORK, June 21 (GenomeWeb News) - The National Institute of Child Health and Human Development will commit $2.5 million in fiscal year 2005 to genomic and proteomic research into premature birth, the NIH said on Friday.

 

The aim is to create a network for premature birth research, consisting of up to three clinical sites responsible for subject recruitment and specimen collection, an analytical core for genomic and proteomic analyses, and a data management, statistics, and informatics core for data management.

 

The network will conduct studies using large-scale genomic and proteomic approaches and make the results available in a public database. The aim is to understand the mechanisms responsible for premature birth, the leading cause of infant morbidity and mortality. Approximately 400,000 babies are born prematurely in the US every year.

 

Applications are due August 20. The RFA can be found here.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.